Total Payments
$1,416
2024 Payments
$462.01
Companies
21
Transactions
61
Medicare Patients
142
Medicare Billing
$11,747
Payment Breakdown by Category
Food & Beverage$1,416 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,416 | 61 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $397.90 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $179.67 | 5 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $159.12 | 3 | $0 (2021) |
| GlaxoSmithKline, LLC. | $128.23 | 2 | $0 (2021) |
| Endo Pharmaceuticals Inc. | $96.49 | 6 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $67.47 | 3 | $0 (2024) |
| Boston Scientific Corporation | $66.56 | 3 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $52.41 | 2 | $0 (2024) |
| Amarin Pharma Inc. | $42.12 | 2 | $0 (2021) |
| Medtronic, Inc. | $30.17 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $462.01 | 29 | ABBVIE INC. ($183.72) |
| 2023 | $157.44 | 8 | ABBVIE INC. ($63.82) |
| 2022 | $48.45 | 2 | Medtronic, Inc. ($30.17) |
| 2021 | $748.50 | 22 | Neurocrine Biosciences, Inc. ($159.12) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: NEUROSCIENCE | ||||||
| 11/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/16/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.39 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.32 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Respiratory | ||||||
| 06/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Respiratory | ||||||
| 06/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.55 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: NEUROSCIENCE | ||||||
| 06/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 05/22/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 05/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.36 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.11 | General |
| Category: NEUROSCIENCE | ||||||
| 04/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: NEUROSCIENCE | ||||||
| 04/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: PAIN | ||||||
| 03/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.02 | General |
| Category: NEUROSCIENCE | ||||||
| 02/26/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $6.99 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 24 | 43 | $6,384 | $2,187 |
| 2021 | 3 | 45 | 79 | $87,407 | $5,586 |
| 2020 | 3 | 73 | 101 | $33,051 | $3,974 |
Total Patients
142
Total Services
223
Medicare Billing
$11,747
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 28 | $5,814 | $2,054 | 35.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 15 | $570.00 | $132.62 | 23.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 22 | 56 | $58,055 | $3,617 | 6.2% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Facility | 2021 | 12 | 12 | $15,143 | $1,155 | 7.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 11 | 11 | $14,209 | $813.66 | 5.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 41 | 53 | $19,179 | $2,376 | 12.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 21 | 23 | $10,673 | $1,423 | 13.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 11 | 25 | $3,199 | $175.20 | 5.5% |
About Jaylin Miller, DNP, APRN, FNP-C
Jaylin Miller, DNP, APRN, FNP-C is a Registered Nurse healthcare provider based in Iowa, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2017. The National Provider Identifier (NPI) number assigned to this provider is 1912421553.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jaylin Miller, DNP, APRN, FNP-C has received a total of $1,416 in payments from pharmaceutical and medical device companies, with $462.01 received in 2024. These payments were reported across 61 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,416).
As a Medicare-enrolled provider, Miller has provided services to 142 Medicare beneficiaries, totaling 223 services with total Medicare billing of $11,747. Data is available for 3 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Primary Care, Family
- Location Iowa, LA
- Active Since 07/26/2017
- Last Updated 05/01/2023
- Taxonomy Code 163W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1912421553
Products in Payments
- UBRELVY (Drug) $174.08
- VRAYLAR (Drug) $148.59
- TRELEGY ELLIPTA (Drug) $128.23
- FARXIGA (Drug) $124.41
- INGREZZA (Drug) $100.03
- NASCOBAL (Drug) $96.49
- QULIPTA (Drug) $75.23
- TRINTELLIX (Drug) $67.47
- Qelbree (Drug) $52.41
- Rezum Generator (Device) $48.28
- Vascepa (Drug) $42.12
- CAPLYTA (Drug) $40.49
- AIRSUPRA (Drug) $34.43
- SONICISION (Device) $30.17
- TRULICITY (Drug) $27.95
- Azstarys (Drug) $25.78
- BREZTRI (Drug) $20.83
- NURTEC ODT (Drug) $18.76
- rezum Generator (Device) $18.28
- HETLIOZ (Drug) $16.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.